Wordt geladen...
Limited efficacy of pixantrone in refractory diffuse large B-cell lymphoma
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is an aggressive disease with poor outcomes in patients ineligible for autologous stem cell transplantation. In this setting, novel treatment approaches are urgently required and the innovative agent pixantrone has shown some promising res...
Bewaard in:
| Gepubliceerd in: | Oncol Lett |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039066/ https://ncbi.nlm.nih.gov/pubmed/32194699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11288 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|